CT Perfusion Stroke
4
Feb

Overview

CT perfusion assesses cerebral blood flow and volume to identify salvageable brain tissue. It complements non contrast CT and CT angiography in acute stroke evaluation. Perfusion maps guide reperfusion therapy decisions.

Acquisition and Processing

Rapid acquisition and automated processing produce perfusion maps for clinical use. Standardized thresholds help identify ischemic core and penumbra. Timely imaging is critical for treatment eligibility.

Clinical Impact

Perfusion imaging expands treatment windows for selected patients by identifying viable tissue. It supports decision making for thrombectomy and thrombolysis. Integration with clinical assessment optimizes outcomes.

Limitations

Perfusion results can vary with acquisition parameters and post processing algorithms. Artifacts and patient motion may affect interpretation. Multidisciplinary protocols ensure appropriate use and interpretation.

Ultrasound in Emergency Medicine
4
Feb

Overview

Point of care ultrasound provides rapid bedside assessment in emergency settings. It aids in diagnosis of trauma cardiac and abdominal emergencies. Training and protocols ensure appropriate use and documentation.

Trauma Use

Focused assessment with sonography for trauma detects free fluid and guides management. It is rapid and repeatable in unstable patients. Integration with other imaging supports comprehensive care.

Cardiac and Vascular

POCUS evaluates cardiac function pericardial effusion and major vascular access. It assists in resuscitation and procedural guidance. Competency based training improves diagnostic accuracy.

Workflow Integration

POCUS findings should be documented and integrated with formal imaging when needed. Quality assurance and image archiving support education and medicolegal standards. Clear communication with the care team enhances patient management.

Radiation Oncology Imaging Biomarkers
4
Feb

Overview

Imaging biomarkers quantify tumor characteristics to personalize radiotherapy. Functional imaging such as PET and MRI provides metrics for hypoxia perfusion and cellularity. Biomarkers support dose painting and adaptive strategies.

Imaging Modalities

PET tracers and MRI parametric maps offer complementary biomarker information. Multiparametric approaches improve characterization of tumor heterogeneity. Standardization is required for clinical implementation.

Clinical Trials

Biomarker driven trials evaluate imaging guided dose escalation and adaptive therapy. Imaging endpoints help assess early response and predict outcomes. Collaboration between imaging and radiation oncology is essential.

Implementation Challenges

Reproducibility and harmonization across scanners and sites are major hurdles. Regulatory and reimbursement frameworks influence adoption. Ongoing validation studies aim to demonstrate clinical benefit.

CT Colonography
4
Feb

Overview

CT colonography provides a minimally invasive option for colorectal screening and polyp detection. It requires bowel preparation and insufflation for optimal visualization. Positive findings typically require colonoscopic confirmation and removal.

Technique

Low dose CT protocols and prone supine imaging improve lesion detection. Computer aided detection assists radiologists in identifying polyps. Quality control and standardized reporting enhance program performance.

Clinical Role

CT colonography is an alternative for patients unable or unwilling to undergo optical colonoscopy. It detects clinically significant polyps and cancers with high sensitivity. Screening programs consider availability and follow up pathways.

Limitations

Extracolonic findings may require additional evaluation and increase downstream testing. Radiation exposure and bowel prep remain considerations for some patients. Shared decision making informs modality choice.

Breast Screening Density
4
Feb

Overview

Breast density affects mammographic sensitivity and cancer detection rates. Dense tissue can mask lesions leading to supplemental imaging considerations. Personalized screening strategies account for density and risk factors.

Supplemental Modalities

Ultrasound and MRI are options for supplemental screening in dense breasts. Each modality has benefits and limitations including false positive rates and cost. Shared decision making guides modality selection.

Risk Communication

Clear communication about density and screening implications supports informed choices. Reporting systems may include density information for clinicians and patients. Education reduces confusion and improves adherence to recommendations.

Research Needs

Studies evaluate outcomes of density based supplemental screening strategies. Evidence on mortality benefit and cost effectiveness informs guidelines. Ongoing research refines risk stratification and screening algorithms.

Contrast Kidney Safety
4
Feb

Overview

Contrast induced nephropathy risk is mitigated by assessing renal function and hydration. Iodinated contrast and gadolinium based agents require tailored approaches. Risk stratification guides imaging choices and preventive measures.

Assessment

Baseline renal function and risk factors inform contrast decisions. Estimated glomerular filtration rate helps determine safety and need for alternatives. Communication with referring clinicians ensures appropriate planning.

Prevention

Hydration and minimizing contrast dose reduce renal risk in susceptible patients. Use of alternative modalities or non contrast protocols may be appropriate. Post procedure monitoring is considered for high risk individuals.

Policy and Education

Institutional protocols standardize assessment and prevention strategies. Staff education on contrast safety improves adherence to best practices. Documentation of decisions supports quality and medicolegal standards.

Whole Body MRI
4
Feb

Overview

Whole body MRI provides radiation free assessment of multiple organ systems in a single exam. It is useful for cancer staging myeloma and systemic inflammatory diseases. Protocols balance coverage with scan time and resolution.

Oncologic Use

Whole body MRI detects bone marrow and soft tissue metastases with high sensitivity. It complements PET CT in certain malignancies and avoids ionizing radiation. Diffusion sequences enhance lesion detection and characterization.

Non Oncologic Use

Whole body MRI can assess systemic inflammatory and metabolic disorders. It provides comprehensive evaluation without radiation exposure. Standardized protocols support multicenter studies and clinical adoption.

Operational Considerations

Long scan times and resource needs require careful scheduling and patient selection. Motion management and sequence optimization improve image quality. Reimbursement and workflow integration influence uptake.

Ultrasound Elastography Liver
4
Feb

Overview

Ultrasound elastography measures liver stiffness as a surrogate for fibrosis. It reduces the need for invasive liver biopsy in many patients. Results must be interpreted in clinical context with other tests.

Techniques

Shear wave and transient elastography are common methods for liver stiffness assessment. Each technique has specific acquisition and interpretation criteria. Operator training and quality control improve reliability.

Clinical Integration

Elastography is used for screening staging and monitoring of chronic liver disease. Serial measurements track progression and response to therapy. Integration with ultrasound and laboratory data enhances decision making.

Limitations

Inflammation congestion and technical factors can affect stiffness measurements. Cutoffs vary by technique and population requiring local validation. Awareness of confounders prevents misclassification.

Low Dose CT Protocols
4
Feb

Overview

Low dose CT protocols aim to reduce patient exposure without compromising diagnostic utility. Advances in reconstruction and detector technology enable dose reduction. Protocol customization is essential for different clinical indications.

Techniques

Iterative reconstruction and automated exposure control are key dose reduction tools. Tube current modulation and kV selection further optimize dose. Protocols must be validated for diagnostic performance.

Pediatric Considerations

Children require tailored low dose protocols and careful justification. Size based protocols and shielding reduce unnecessary exposure. Communication with caregivers supports informed imaging decisions.

Quality Monitoring

Dose tracking and audit ensure protocols remain effective and safe. Benchmarking against standards guides continuous improvement. Education of technologists and radiologists supports consistent practice.

Advanced PET Tracers
4
Feb

Overview

New PET tracers target specific molecular pathways to improve disease detection. These tracers expand applications beyond standard metabolic imaging. Clinical translation requires validation and regulatory approval.

Clinical Uses

Targeted tracers enable imaging of receptors inflammation and cellular processes. They improve specificity for oncologic and neurologic indications. Tracer selection depends on the clinical question and availability.

Production and Logistics

Radiochemistry and distribution affect tracer accessibility and scheduling. Short half life tracers require local production or rapid transport. Infrastructure investment supports broader clinical use.

Future Directions

Novel tracers paired with hybrid imaging enhance precision medicine. Quantitative PET metrics support therapy selection and monitoring. Ongoing trials will define clinical roles and cost effectiveness.